Reports - Psoriatic Arthritis (PsA) Treatment Market
HealthcarePsoriatic Arthritis (PsA) Treatment Market
Psoriatic Arthritis (PsA) Treatment Market Size & Share | Growth Analysis 2035 by Drug Class (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Disease-Modifying Antirheumatic Drugs (DMARDs), Biologics and Biosimilars, Corticosteroids, Others (PDE4 Inhibitors)) by Type of Treatment (Prescription-based, Over-the-Counter (OTC)) by Route of Administration (Oral, Injectable, Topical) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Psoriatic Arthritis (PsA) Treatment Market - Segment Analysis
1. Overview
2. Global Psoriatic Arthritis (PsA) Treatment Market, 2021 - 2034 (USD Million)
3. Global Psoriatic Arthritis (PsA) Treatment Market - by Drug Class
3.1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
3.2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
3.3. By Biologics and Biosimilars
3.4. By Corticosteroids
3.5. By Others (PDE4 Inhibitors)
4. Global Psoriatic Arthritis (PsA) Treatment Market - by Type of Treatment
4.1. By Prescription-based
4.2. By Over-the-Counter (OTC)
5. Global Psoriatic Arthritis (PsA) Treatment Market - by Route of Administration
5.1. By Oral
5.2. By Injectable
5.3. By Topical
6. Global Psoriatic Arthritis (PsA) Treatment Market - by Distribution Channel
6.1. By Hospital Pharmacies
6.2. By Retail Pharmacies
6.3. By Online Pharmacies
7. Global Psoriatic Arthritis (PsA) Treatment Market - by region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Market comparative analysis
Chapter 4 North America Psoriatic Arthritis (PsA) Treatment Market - Segment Analysis
1. Overview
2. North America Psoriatic Arthritis (PsA) Treatment Market, 2021 - 2034 (USD Million)
3. North America Psoriatic Arthritis (PsA) Treatment Market - by Drug Class
3.1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
3.2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
3.3. By Biologics and Biosimilars
3.4. By Corticosteroids
3.5. By Others (PDE4 Inhibitors)
4. North America Psoriatic Arthritis (PsA) Treatment Market - by Type of Treatment
4.1. By Prescription-based
4.2. By Over-the-Counter (OTC)
5. North America Psoriatic Arthritis (PsA) Treatment Market - by Route of Administration
5.1. By Oral
5.2. By Injectable
5.3. By Topical
6. North America Psoriatic Arthritis (PsA) Treatment Market - by Distribution Channel
6.1. By Hospital Pharmacies
6.2. By Retail Pharmacies
6.3. By Online Pharmacies
Chapter 5 Europe Psoriatic Arthritis (PsA) Treatment Market - Segment Analysis
1. Overview
2. Europe Psoriatic Arthritis (PsA) Treatment Market, 2021 - 2034 (USD Million)
3. Europe Psoriatic Arthritis (PsA) Treatment Market - by Drug Class
3.1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
3.2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
3.3. By Biologics and Biosimilars
3.4. By Corticosteroids
3.5. By Others (PDE4 Inhibitors)
4. Europe Psoriatic Arthritis (PsA) Treatment Market - by Type of Treatment
4.1. By Prescription-based
4.2. By Over-the-Counter (OTC)
5. Europe Psoriatic Arthritis (PsA) Treatment Market - by Route of Administration
5.1. By Oral
5.2. By Injectable
5.3. By Topical
6. Europe Psoriatic Arthritis (PsA) Treatment Market - by Distribution Channel
6.1. By Hospital Pharmacies
6.2. By Retail Pharmacies
6.3. By Online Pharmacies
Chapter 6 Asia Pacific Psoriatic Arthritis (PsA) Treatment Market - Segment Analysis
1. Overview
2. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market, 2021 - 2034 (USD Million)
3. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market - by Drug Class
3.1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
3.2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
3.3. By Biologics and Biosimilars
3.4. By Corticosteroids
3.5. By Others (PDE4 Inhibitors)
4. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market - by Type of Treatment
4.1. By Prescription-based
4.2. By Over-the-Counter (OTC)
5. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market - by Route of Administration
5.1. By Oral
5.2. By Injectable
5.3. By Topical
6. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market - by Distribution Channel
6.1. By Hospital Pharmacies
6.2. By Retail Pharmacies
6.3. By Online Pharmacies
Chapter 7 Latin America Psoriatic Arthritis (PsA) Treatment Market - Segment Analysis
1. Overview
2. Latin America Psoriatic Arthritis (PsA) Treatment Market, 2021 - 2034 (USD Million)
3. Latin America Psoriatic Arthritis (PsA) Treatment Market - by Drug Class
3.1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
3.2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
3.3. By Biologics and Biosimilars
3.4. By Corticosteroids
3.5. By Others (PDE4 Inhibitors)
4. Latin America Psoriatic Arthritis (PsA) Treatment Market - by Type of Treatment
4.1. By Prescription-based
4.2. By Over-the-Counter (OTC)
5. Latin America Psoriatic Arthritis (PsA) Treatment Market - by Route of Administration
5.1. By Oral
5.2. By Injectable
5.3. By Topical
6. Latin America Psoriatic Arthritis (PsA) Treatment Market - by Distribution Channel
6.1. By Hospital Pharmacies
6.2. By Retail Pharmacies
6.3. By Online Pharmacies
Chapter 8 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market - Segment Analysis
1. Overview
2. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market, 2021 - 2034 (USD Million)
3. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market - by Drug Class
3.1. By Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
3.2. By Disease-Modifying Antirheumatic Drugs (DMARDs)
3.3. By Biologics and Biosimilars
3.4. By Corticosteroids
3.5. By Others (PDE4 Inhibitors)
4. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market - by Type of Treatment
4.1. By Prescription-based
4.2. By Over-the-Counter (OTC)
5. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market - by Route of Administration
5.1. By Oral
5.2. By Injectable
5.3. By Topical
6. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market - by Distribution Channel
6.1. By Hospital Pharmacies
6.2. By Retail Pharmacies
6.3. By Online Pharmacies
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. AbbVie Inc.
2. Amgen Inc.
3. Johnson & Johnson (Janssen Pharmaceuticals)
4. Pfizer Inc.
5. Bristol-Myers Squibb
6. Novartis AG
7. UCB S.A.
8. Eli Lilly and Company
9. Biogen
10. Merck KGaA
11. Sanofi
12. Teva Pharmaceuticals
13. Fujifilm Kyowa Kirin Biologics
14. Samsung Bioepis
15. Sun Pharmaceutical Industries.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By